Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model

Figure 3

(a) Detailed information relating to changes in the biological processes (BP) of DEGs in ccRCC and normal kidney tissue. (b) Detailed information relating to changes in the cellular components (CC) of DEGs in ccRCC and normal kidney tissue. (c) Detailed information relating to changes in the molecular functions (MF) of DEGs in ccRCC and normal kidney tissue. (d) KEGG pathway analysis for DEGs. (e) The BP analysis for DEGs via the BiNGO software.

(a)

(b)

(c)

(d)

(e)